Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
about
Trial watch - inhibiting PARP enzymes for anticancer therapyMechanism of ADP-ribosylation removal revealed by the structure and ligand complexes of the dimanganese mono-ADP-ribosylhydrolase DraGAssociation between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer.PARP-1 Val762Ala polymorphism and risk of cancer: a meta-analysis based on 39 case-control studies.Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain lengthThe joint effect of hOGG1, APE1, and ADPRT polymorphisms and cooking oil fumes on the risk of lung adenocarcinoma in Chinese non-smoking femalesPARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.Functional Aspects of PARP1 in DNA Repair and Transcription.Poly(ADP-ribosylation) is present in murine sciatic nerve fibers and is altered in a Charcot-Marie-Tooth-1E neurodegenerative model.A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs.Hydrolysis of O-acetyl-ADP-ribose isomers by ADP-ribosylhydrolase 3.Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells.Association of three SNPs in the PARP-1 gene with Hashimoto's thyroiditis.PolyADP-ribosylation and cancer.Modeling prostate cancer in mice: limitations and opportunitiesThe Effect of Poly(ADP-ribose) Polymerase-1 Gene 3'Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort.PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.PARP inhibitorsPoly(ADP-ribose) glycohydrolase silencing down-regulates TCTP and Cofilin-1 associated with metastasis in benzo(a)pyrene carcinogenesis.VERO cells harbor a poly-ADP-ribose belt partnering their epithelial adhesion belt.Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins.Characterization of the promoter region of the human PARG gene and its response to PU.1 during differentiation of HL-60 cells.Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity.Parp-1 deficiency in ES cells promotes invasive and metastatic lesions accompanying induction of trophoblast giant cells during tumorigenesis in uterine environment.Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.Lack of association between poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population.Antagonistic crosstalk between SIRT1, PARP-1, and -2 in the regulation of chronic inflammation associated with aging and metabolic diseases.Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).Deletion of poly(ADP‑ribose) polymerase-1 changes the composition of the microbiome in the gut
P2860
Q26745673-B84BDD51-0B75-4471-BCE5-7CDC6E0EFE57Q27657174-DCBD2A1B-8110-454D-B851-4CFCA9A4243BQ28382839-067F80A9-870A-4246-8A28-34DD7D0AC0F1Q28383483-284A5963-FEA1-4892-92DC-9C6D325E467FQ28386519-75F6FF75-30C1-4280-9E9B-AB4F6BC97E09Q30835893-500C5810-8E27-49F8-904A-3AD257559487Q31126536-9FFCEC45-8EC3-4D90-B1E1-CFD6F120B18DQ33536164-ED040E1A-78BC-49DD-9D15-9436B881F7ABQ33649584-E4D6D05A-E2F6-414D-A256-9E7B1B74A7F2Q33671359-D2989184-E2C6-4C53-9287-26004B09BF88Q34990282-C34F2393-DE3B-44B5-9B1E-F54348FD2F77Q35065114-1A0E547F-52A4-4CC8-B6DE-2F6F35D8B281Q36464461-73EFD59A-A9CA-4F68-B02A-537C752C890AQ36621346-14C7EBF0-960F-4BD1-B097-0EF8C57D3355Q36671116-C360B19D-83B0-4C04-B415-9E920F1AD3A1Q36889328-D3C2E4E1-CD56-4554-80CD-90A01E7A6A84Q37053034-7C0F2C1A-528B-49DE-9320-8085FE93A3C8Q37322627-4A410450-C1F8-4A52-91BF-57CEAEB81E6BQ37377750-39964FC5-7350-4590-81DC-2FD7EFD97866Q37990715-5CA1F801-4F34-4DE1-B0D5-338319FED280Q38326336-9D1865FB-3BCE-4A98-9030-D8AA13E62C5FQ38915776-7D63129B-C371-4E32-AD9A-4600FC1A455CQ38946365-F302CDCE-680C-4EE2-8FBE-582ADCE0DE06Q41866484-FD78CC2B-2341-4FEB-ABE2-183CDC6A3149Q42446442-A6C2EC73-B352-4448-8442-FE284B074CD3Q42612100-59EF625E-5005-4395-A4FE-921B054949C9Q47748438-FE25306B-628F-454E-A28F-4C642461AB62Q48332972-393AB1E1-698B-4372-B651-C0B2FF327E74Q53463206-34F296DF-AD7E-4B9B-8308-B8E6D6E8DD32Q53828950-6412BDEB-915E-407D-BE79-18A24999B224Q54317183-DEFA544C-690D-4D7D-BD51-63E0D05C163EQ58752969-C6D8FE3C-F771-444F-A05B-5AF753F291FB
P2860
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@ast
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@en
type
label
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@ast
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@en
prefLabel
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@ast
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@en
P2093
P1476
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
@en
P2093
Masutani M
Nakagama H
Sugimura T
P2888
P304
P356
10.1007/S00018-004-4509-X
P577
2005-04-01T00:00:00Z